M D Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT04189770
This trial studies the day-to-day stress, social support, and health lifestyle behaviors (such as physical activity and nutrition) in African American patients with stage 0-III prostate cancer survivors and their partners. How patients cope with stress may affect their lifestyle behaviors. This study may help understand not only survivors' behaviors but also partners' behaviors and how they interact.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Houston, Texas, 77030, United States
PRIMARY OBJECTIVES:
I. Examine temporal associations between dyadic coping and health behaviors such as physical activity and diet.
II. Identify social and physical contexts in which health behaviors occur/co-occur among survivors and their partners.
EXPLORATORY OBJECTIVE:
I. Investigate potential moderators for the associations between stress and dyadic coping.
OUTLINE:
Patients and partners complete questionnaires over 60 minutes about demographic information, stress, coping, and lifestyle behaviors at baseline and end of study. Patients and partners also receive an accelerometer and complete Ecological Momentary Assessment (EMA) questionnaire on stress, coping, physical activity, and eating behaviors over 5-10 minutes four time daily (QID; 7:30 am, 11:30 am, 3:30 pm, and 7:30 pm) via an smartphone application (app) for 14 days. Patients and partners also complete a survey on nutrition twice weekly (BIW) for a total of 4 surveys.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wear accelerometer
Complete EMA questionnaire
Other names: EMA
Complete questionnaire
Complete survey
Time frame: Up to 14 days
To assess the association between the common dyadic coping of partner or survivor and physical activity of the survivor or partner, will construct 2 new variables corresponding to each common dyadic coping variable for each individual.
Time frame: Up to 14 days
To assess the association between the common dyadic coping of partner or survivor and nutrition of the survivor or partner, will construct 2 new variables corresponding to each common dyadic coping variable for each individual.
Time frame: Up to 14 days
To assess the association between the common dyadic coping of partner or survivor and nutrition of the survivor or partner, will construct 2 new variables corresponding to each common dyadic coping variable for each individual.
Time frame: Up to 14 days
Descriptive analysis (e.g., frequency) will be conducted to examine the places (e.g., home, neighborhood) in which the health behaviors occurred and the number of health behaviors engaged alone and with others (especially with partner). Also, contexts (days of a week and times of a day and place) in which survivors and partners engaged in health behaviors together will be investigated. All analyses will be exploratory in nature.
M.D. Anderson Cancer Center
Other
One Plus One Can Be Greater Than Two: Ecological Momentary Assessment for Black Prostate Cancer Survivors and Partners
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04215029
Cancer Survivor, Genital Diseases
Houston, Texas, United States
View Trial DetailsNCT03035500
Cancer Survivor, Genital Diseases
Duarte, California, United States
View Trial DetailsNCT03880422
Body Weight, Cancer Survivor
Buffalo, New York, United States
View Trial DetailsNCT03406013
Cancer Survivor, Genital Diseases
San Francisco, California, United States
View Trial Details